Orange Book product · Brand (NDA)
XARTEMIS XR
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
At a glance
Mar 11, 2014
Approved
Brand (NDA)
Application
Not listed
TE code
12
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 11, 2014
12 yr 5 mo ago
Today
Patent 7976870 expires
Listed method-of-use patent (U-1498) expiration.
Jun 01, 2027
in 1 yr
Patent 8372432 expires
Listed drug product patent expiration.
Mar 11, 2029
in 2 yr 9 mo
Patent 8394408 expires
Listed drug product patent expiration.
Mar 11, 2029
in 2 yr 9 mo
Patent 8668929 expires
Listed method-of-use patent (U-1499) expiration.
Mar 11, 2029
in 2 yr 9 mo
Patent 8377453 expires
Listed drug product patent expiration.
Nov 19, 2029
in 3 yr 6 mo
Patent 8597681 expires
Listed drug product patent expiration.
Dec 21, 2030
in 4 yr 7 mo
Patent 8980319 expires
Listed drug product patent expiration.
Dec 21, 2030
in 4 yr 7 mo
Patent 8658631 expires
Listed drug product patent expiration.
May 16, 2032
in 6 yr
Patent 8741885 expires
Listed drug product patent expiration.
May 16, 2032
in 6 yr
Patent 8992975 expires
Listed drug product patent expiration.
May 16, 2032
in 6 yr
Patent 9050335 expires
Listed drug product patent expiration.
May 16, 2032
in 6 yr
Patent 9468636 expires
Listed method-of-use patent (U-1499) expiration.
May 16, 2032
in 6 yr
Pharmaceutical detail
Active ingredient
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
Strength
325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 204031
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2021OXYCODONE AND ACETAMINOPHENGeneric (ANDA)
ANDA 201448 · SANKALP LIFECARE
- 2019OXYCODONE AND ACETAMINOPHENGeneric (ANDA)
ANDA 211708 · GRANULES
- 2019OXYCODONE AND ACETAMINOPHENGeneric (ANDA)
ANDA 207834 · CHARTWELL
- 2018OXYCODONE AND ACETAMINOPHENGeneric (ANDA)
ANDA 211499 · ABHAI LLC
- 2018OXYCODONE AND ACETAMINOPHENGeneric (ANDA)
ANDA 202142 · MIKART
- 2018OXYCODONE AND ACETAMINOPHENGeneric (ANDA)
ANDA 209385 · ELITE LABS INC
- 2018OXYCODONE AND ACETAMINOPHENGeneric (ANDA)
ANDA 203864 · EPIC PHARMA LLC
- 2018OXYCODONE AND ACETAMINOPHENGeneric (ANDA)
ANDA 210644 · ABHAI LLC
- 2017OXYCODONE AND ACETAMINOPHENGeneric (ANDA)
ANDA 210079 · NESHER PHARMS
- 2017OXYCODONE AND ACETAMINOPHENGeneric (ANDA)
ANDA 207333 · LANNETT CO INC
- 2017OXYCODONE AND ACETAMINOPHENGeneric (ANDA)
ANDA 207419 · ASCENT PHARMS INC
- 2017OXYCODONE AND ACETAMINOPHENGeneric (ANDA)
ANDA 204407 · NOVEL LABS INC
Listed patents (12)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7976870 | Jun 01, 2027 | in 1 yr | U-1498 |
| 8372432 | Mar 11, 2029 | in 2 yr 9 mo | ProductU-1499 |
| 8394408 | Mar 11, 2029 | in 2 yr 9 mo | Product |
| 8668929 | Mar 11, 2029 | in 2 yr 9 mo | U-1499 |
| 8377453 | Nov 19, 2029 | in 3 yr 6 mo | ProductU-1499 |
| 8597681 | Dec 21, 2030 | in 4 yr 7 mo | Product |
| 8980319 | Dec 21, 2030 | in 4 yr 7 mo | Product |
| 8658631 | May 16, 2032 | in 6 yr | Product |
| 8741885 | May 16, 2032 | in 6 yr | ProductU-1499 |
| 8992975 | May 16, 2032 | in 6 yr | Product |
| 9050335 | May 16, 2032 | in 6 yr | Product |
| 9468636 | May 16, 2032 | in 6 yr | U-1499 |

